NCT04147910View on ClinicalTrials.gov

Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

August 21, 2019

Primary Completion Date

October 2, 2019

Study Completion Date

October 2, 2019

Conditions

Healthy Male Subjects

Interventions

DRUG

KW-6356

Single oral dose of KW-6356

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.

All Listed Sponsors

lead

Kyowa Kirin, Inc.

INDUSTRY